| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/15/2007 | CN1331462C Self microemulsion of total dragon's blood flavone |
| 08/15/2007 | CN101018846A Method for producing unsaturated fatty acid concentrate |
| 08/15/2007 | CN101018799A Composition and method for inhibiting platelet aggregation |
| 08/15/2007 | CN101018565A Methods for treating conditions associated with MASP-2 dependent complement activation |
| 08/15/2007 | CN101018546A (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 08/15/2007 | CN101016560A Method of measuring biologically active substance vitality, cardiomyopeptidin and use thereof |
| 08/15/2007 | CN101016557A Muskrat fragrant active component prepared by external secretion, preparing process and use |
| 08/15/2007 | CN101015699A Polyethylene glycol-phosphatidyl ethanolamine polymer or medicinal acid addition salt and application thereof in pharmacy |
| 08/15/2007 | CN101015693A Use of CD25 binding molecules in steroid-resistant patients. |
| 08/15/2007 | CN101015652A Health-care medicated wine for person in middle and old age |
| 08/15/2007 | CN101015632A Medicine for treating coronary heart disease and preparation method thereof |
| 08/15/2007 | CN101015620A Biological capsule for treating cardiac and cerebral vascular diseases |
| 08/15/2007 | CN101015606A Traditional Chinese medicine composition for preventing and treating cardiovascular and cerebrovascular diseases and preparing process thereof |
| 08/15/2007 | CN101015596A Chinese patent drug for curing angiocardiopathy and cerebrovascular disease and its preparing method |
| 08/15/2007 | CN101015592A Compound Chinese medicine preparation of breviscapine |
| 08/15/2007 | CN101015584A Traditional Chinese medicine Ningxintong preparation for treating unstable angina in the coronary heart disease and preparation method thereof |
| 08/15/2007 | CN101015577A Preparing method of fleabane extract dry matter |
| 08/15/2007 | CN101015576A Medicine for preventing and treating cardiovascular and cerebrovascular diseases by increasing hypoxia-resistant ability and its preparing method |
| 08/15/2007 | CN101015562A DiAo Xinxuekang soft capsule and preparation process and use thereof |
| 08/15/2007 | CN101015557A Combination of an inhibitor of the if current of the sinus node and an inhibitor of the angiotensin converting enzyme, and pharmaceutical ingredients containing said association |
| 08/15/2007 | CN101015556A New association of an if sinusoidal current inhibitor and a calcium channel-blocking agent, and pharmaceutical ingredients containing said association |
| 08/15/2007 | CN101015552A Ligustilide extract and its preparing process and application |
| 08/15/2007 | CN101015546A Verapamil formulation absorbed by oral or nasal mucous membrane |
| 08/15/2007 | CN101015543A Use of cinnamic acid and allyl benzoate compound with oxidation resistance function for protecting liver and brain damage |
| 08/15/2007 | CN101015504A Method for producing suppository for treating uterus adenomyosis |
| 08/15/2007 | CN101015353A Pure natural oxygenation health care beverage and compounding process thereof |
| 08/15/2007 | CN101015345A Health-care food with hypoxia-resistant and immunity-enhancing functions and its preparing process |
| 08/15/2007 | CN101015334A Chinese toon sauce with local flavor and its preparation |
| 08/14/2007 | US7257419 Method for attempting to establish a connection between a mobile station and a wireless communication system including a parameter identifying reason for a previously failed reconnection attempt and a parameter indicating a number of times that the reason occurred |
| 08/14/2007 | US7256307 Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor α(PPAR) |
| 08/14/2007 | US7256267 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 |
| 08/14/2007 | US7256217 Prodrugs of excitatory amino acids |
| 08/14/2007 | US7256212 Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 08/14/2007 | US7256211 Containing a carboxy-substituted thiazolylthio group, e.g., 15 alpha ,13E)-9-oxo-15-hydroxy-16-(4-fluoro-3-phenylphenyl)-5-(4-carboxythiazol-2-yl)-1,2,3,4,17,18,19,20-octanol-5-thia-8-azaprost-13-ene; EP4 agonistic action and are useful for treating diseases including immunological disorders and asthma |
| 08/14/2007 | US7256201 Selective estrogen receptor-β ligands |
| 08/14/2007 | US7256199 2-(Substituted amino)-6-(4-pyridyl)pyrimidin-4-ones, e.g., 2-(N-phenylamino)-6-(4-pyridyl)pyrimidin-4-one and 2-(N-(3-bromophenyl)amino)-6-(4-pyridyl)pyrimidin-4-one; treatment of diseases caused by tau protein kinase 1 hyperactivity such as Alzheimer disease. |
| 08/14/2007 | US7256194 Compounds that inhibit factor Xa activity |
| 08/14/2007 | US7256193 Therapeutic agents useful for treating pain |
| 08/14/2007 | US7256189 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone der derivatives as protein kinase inhibitors |
| 08/14/2007 | US7256183 Administering a nucleotide receptor agonist (such as adenosine triphophate or uridine triphosphate); sinusitis, rhinitis, conjunctivitis, asthma, dermatitis, inflammatory collagen vascular diseases, glomerulonephritis; antiallergens |
| 08/14/2007 | US7256178 Physiologically active substances |
| 08/14/2007 | US7256043 Transfection complexes |
| 08/14/2007 | US7256028 Methods for screening compounds that modulate lipid metabolism |
| 08/14/2007 | US7255879 Extracting and recovering embryonic-like stem cells, including pluripotent or multipotent stem cells, from an exsanguinated human placenta; use of the isolated and perfused placenta as a bioreactor in which to propagate endogenous/exogenous cells |
| 08/14/2007 | US7255850 The rates of the two arms of reverse cholesterol transport (HDL or first arm and post-HDL or second arm) are obtained by measuring the flow of unlabeled cholesterol from tissues into plasma HDL and from plasma HDL to bile acids |
| 08/14/2007 | CA2370030C Sodium channel blocker compositions and the use thereof |
| 08/14/2007 | CA2281708C Process for preparing eprosartan |
| 08/14/2007 | CA2251016C .alpha.1-adrenergic receptor antagonists |
| 08/14/2007 | CA2223414C Heteroaryl diol acids as leukotriene antagonists |
| 08/14/2007 | CA2213714C Phenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 08/14/2007 | CA2206758C Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 08/14/2007 | CA2166328C Prostacyclin synthase derived from human |
| 08/14/2007 | CA2150937C Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 08/09/2007 | WO2007090095A2 Synthesis of carotenoid analogs or derivatives with improved antioxidant characteristics |
| 08/09/2007 | WO2007089787A2 Compositions and methods for treating cardiovascular, cerebrovascular and other vascular disease patients |
| 08/09/2007 | WO2007089683A1 Amido compounds and their use as pharmaceuticals |
| 08/09/2007 | WO2007089655A1 Occupant classification system |
| 08/09/2007 | WO2007089544A2 Biodegradable non-ophthalmic implants and related methods |
| 08/09/2007 | WO2007089034A1 Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents |
| 08/09/2007 | WO2007088895A1 3-arylamino-1,2,4-triazole derivative |
| 08/09/2007 | WO2007088681A1 Ghrelin production promoter |
| 08/09/2007 | WO2007088528A1 Microtubule targeting agents |
| 08/09/2007 | WO2007088514A1 Secondary amines as renin inhibitors |
| 08/09/2007 | WO2007088460A2 Tgf-beta modulators and use thereof |
| 08/09/2007 | WO2007088418A1 Drug-eluting intravascular prostheses and methods of use |
| 08/09/2007 | WO2007088063A1 Acid addition salts of n-{3-[4-(2-methoxyphenyl)-l-piperazinyl]-propyl}-7-oxo-5- trifluoromethyl-7h-thieno[3,2-b]pyran-3-carboxamide |
| 08/09/2007 | WO2007088035A1 A pharmaceutical composition comprising perindopril |
| 08/09/2007 | WO2007088019A1 Use of naphthyridine derivatives as medicaments |
| 08/09/2007 | WO2007087722A1 Use of soy kefir powder for reducing pain, blood pressure and inflammation |
| 08/09/2007 | WO2007087673A1 Domain antibody construct |
| 08/09/2007 | WO2007073186A3 Use of c1 inhibitor for the prevention of ischemia-reperfusion injury |
| 08/09/2007 | WO2007071840A3 Compounds based on four aromatic rings, preparation and uses thereof |
| 08/09/2007 | WO2007054269A3 Extracts from the bark of corynanthe species, use thereof, and medicaments, dietary products, and pharmaceutical preparations containing said extracts |
| 08/09/2007 | WO2006130688A3 Compounds for inhibiting cathepsin activity |
| 08/09/2007 | WO2005123725A9 Novel compound having lipase inhibitory activity |
| 08/09/2007 | US20070185183 Indolinesulphanilic acid amides as ppar-delta modulators |
| 08/09/2007 | US20070185181 Treatment or prevention of hypotension and shock |
| 08/09/2007 | US20070185174 Use of thiazole derivatives for preparing a medicament intended to protect the mitochondria |
| 08/09/2007 | US20070185169 2-Mercapto-4,5-Diarylimidazole Derivatives and the use thereof as Cyclooxygenase Inhibitors |
| 08/09/2007 | US20070185168 Piperidine derivatives |
| 08/09/2007 | US20070185151 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 08/09/2007 | US20070185127 2-(Arylalkoxy)-1-phenylethylamine derivatives as nk1 antagonist and serotonin reuptake inhibitors |
| 08/09/2007 | US20070185112 Piperidine/piperazine-type inhibitors of p38 kinase |
| 08/09/2007 | US20070185048 ATP-binding cassette transporter polypeptide which regulates metabolism of triglycerides; treatment of obesity and eating disorders |
| 08/09/2007 | US20070185037 Sulfated oligosaccharide derivatives |
| 08/09/2007 | US20070185020 Methods and compositions for treating disorders of the extracellular matrix |
| 08/09/2007 | US20070185011 Individual is not exposed to C1INH for longer than required, since levels of the C1INH more rapidly subsides after administration has stopped; side effect reduction |
| 08/09/2007 | US20070184435 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 08/09/2007 | US20070184151 Use of a polyamine-poor composition for the production of a medical human food |
| 08/09/2007 | US20070184112 Volume Efficient Controlled Release Dosage Form |
| 08/09/2007 | US20070184058 Glucocerebroside treatment of pulmonary or respiratory diseases or disorders |
| 08/09/2007 | US20070183983 Medical composition containing nf-kb decoy for treating and preventing respir atory diseases and method of using the same |
| 08/09/2007 | US20070181124 Method and apparatus for dispensing inhalator medicament |
| 08/09/2007 | CA2641303A1 Na/k-atpase ligand |
| 08/09/2007 | CA2640661A1 Domain antibody construct |
| 08/09/2007 | CA2640615A1 Compositions and methods for treating cardiovascular, cerebrovascular and other vascular disease patients |
| 08/09/2007 | CA2640030A1 Biodegradable non-ophthalmic implants and related methods |
| 08/09/2007 | CA2637662A1 Drug-eluting intravascular prostheses and methods of use |
| 08/09/2007 | CA2637546A1 Secondary amines as renin inhibitors |
| 08/09/2007 | CA2637316A1 A pharmaceutical composition comprising perindopril |